🟢 RISK-ON Continues (Weakening) — S&P 500 flat at 7,520.36 (+0.02%) as markets digest a massive oil crash (WTI -4.78% to $89.40) and await CRM/MRVL earnings tonight. VIX stable at 16.32, firmly sub-20. However, regime ensemble confidence continues declining to 49.9% — barely above coin-flip territory. The scan rotates toward quality mega-caps + defensive healthcare, with oil crash beneficiaries (autos, airlines) replacing energy exposure. PCE Friday is the week’s defining macro event.
⚠ PCE Friday — Binary Event for Rate Path: Core PCE due Friday May 30 (consensus +3.3% YoY). A hot print above 4.0% eliminates rate cut hopes for 2026 and likely triggers a 3-5% correction in high-PE tech. A cool print below 3.0% extends the rally. All 10-day horizons in this scan traverse this catalyst. Position sizing should reflect binary risk — regime-rotation-penalty advisory remains active.
⚠ Regime Confidence 49.9% — Weakening Further: RISK-ON score 85 but ensemble confidence down to 49.9% (from 48.4%). 5-day transition probabilities: risk_on 43.7%, crisis 10.6%. Rotation-penalty advisory still active (2 regime changes in 5 scanner days). Recommendation: position size -30%, stops ×1.5 ATR where possible.
The regime score stands at 0.50, classified as RISK-ON. Ensemble model: risk_on 49.9%, neutral 32.5%, early_risk_off 14.3%, crisis 3.3%. 5-day transition: risk_on 43.7%, neutral 26.6%, early_risk_off 19.2%, crisis 10.6%. Expected SPY return +0.22% with expected drawdown -2.6%. Strategy weights: Momentum 45%, Breakout 30%, Pullback 15%, Pre-Squeeze 10%. Regime-rotation-penalty advisory remains active.
Session strategy: Three themes define Thursday’s positioning: (1) AI infrastructure backbone — AMD, ASML capture the AI capex cycle with fresh BUY signals; CRM/MRVL earnings tonight set the sentiment for this cluster; (2) Healthcare dual exposure — LLY (GLP-1 leader), NVS (value pharma), XLV (sector ETF) provide defensive ballast with upside optionality; (3) Breadth + macro plays — AAPL breakout to ATH, IWM small-cap breakout confirming broad participation, CAT on infrastructure, TM as oil crash beneficiary. AMZN anchors the portfolio with cloud/AI + e-commerce trifecta. Avoid energy, avoid earnings-proximate names (DELL, COST, BBY all report 5/28).
Thursday, May 28, 2026
US 🇺🇸
Breakout
Score 90
ATH Breakout
☪ Halal
Apple is breaking out to all-time highs at $313.26, the most significant technical event for the world’s most widely held stock. BUY signal May 5 at $278.08 has delivered +11.8% in 22 sessions — the breakout is confirmed by massive options flow with 47K+ call volume at the 310 strike and 154K at 312.5. RSI at 78.8 is elevated but ATH breakouts routinely sustain 80+ RSI for 5-10 sessions as momentum algorithms pile in. Apple Intelligence AI integration, the iPhone 17 cycle, and Services revenue growth provide fundamental catalysts through the summer. The only concern is high fwd PE (32.4), making it sensitive to a hot PCE print.
✅ Confirmations
- All-time high breakout at $313.26 — no overhead resistance, clean technical runway
- Massive bullish call flow: 47K volume at $310 strike, 154K at $312.5 (16.8× multiplier)
- BUY signal May 5 at $278.08; +11.8% appreciation confirms institutional participation
- Apple Intelligence (AI integration) + iPhone 17 cycle + Services ARPU = triple catalyst
- Above all EMAs: EMA20 $294.70, EMA50 $280.81, EMA200 $260.81 — structural uptrend
❌ Invalidations
- Break below $301 (stop, 3.2%) signals ATH breakout failure — exit immediately
- Hot PCE (>4.0%) compresses fwd PE 32.4 — highest PE in this scan, most rate-sensitive
- FOMC Minutes (Wed) hawkish surprise on rate path uncertainty targeting growth multiples
- China iPhone sales data weakness or EU antitrust escalation (DMA enforcement)
Entry: $308–$314
Stop Loss: $301.00
TP1: $326.00
TP2: $342.00
R/R: 1:1.50
Horizon: 10 days
EU 🇪🇺
Breakout
Score 90
EUV Monopoly
☪ Halal
ASML is the monopoly supplier of EUV lithography equipment essential for every advanced semiconductor fab globally. BUY signal May 21 at $1,557 is active with RSI at a comfortable 58.2 — the most technical room of any top-5 name. The $1,670 call strike shows institutional interest above current price. ASML’s order backlog extends through 2027+ as TSMC, Samsung, and Intel all expand AI-focused fab capacity. The -2.09% session dip creates an improved entry. Fwd PE 33.6 is above average but justified by monopoly pricing power and zero competition.
✅ Confirmations
- BUY signal May 21 at $1,557; RSI 58.2 provides substantial expansion room
- EUV monopoly: zero competitors; every sub-3nm chip globally requires ASML equipment
- Bullish call activity at $1,670 strike — institutional targeting above current price
- AI capex cycle driving multi-year fab expansion (TSMC, Samsung, Intel, US CHIPS Act fabs)
- -2.09% session dip improves entry; near 52W high $1,653 provides clear breakout target
❌ Invalidations
- Break below $1,503 (stop, 5.9%) = breakout failure; exit immediately
- US-China chip restriction tightening blocking ASML from Chinese customers (20%+ revenue)
- MRVL earnings miss tonight signals AI chip demand deceleration; indirect ASML headwind
- Hot PCE compresses fwd PE 33.6; ASML is the highest-PE EU name in the scan
Entry: $1,582–$1,614
Stop Loss: $1,503.00
TP1: $1,745.00
TP2: $1,820.00
R/R: 1:1.55
Horizon: 10 days
US 🇺🇸
Momentum
Score 89
Infrastructure Cycle
☪ Halal
Caterpillar is the global infrastructure bellwether, benefiting from three secular tailwinds: (1) CHIPS Act + IRA domestic manufacturing buildout, (2) global data center construction for AI, and (3) emerging market infrastructure demand. BUY signal May 20 at $872.56 is fresh (+4.3%). RSI at 61.2 is the healthiest industrial in the scan, with room to expand. Near 52W high $931.35 with bullish call activity at the $950 strike. The oil crash is neutral-to-positive for CAT (lower diesel/mining input costs, though mining demand may soften). CAT provides non-tech cyclical diversification to the portfolio.
✅ Confirmations
- BUY signal May 20 at $872.56; fresh and only +4.3% into the move
- RSI 61.2 — healthiest large-cap industrial; room for expansion to 70+
- CHIPS Act + IRA + global data center buildout = multi-year infrastructure capex cycle
- Bullish call at $950 strike (4.7× multiplier) targeting above 52W high $931
- Oil crash neutral-to-positive: lower diesel costs for equipment operations
❌ Invalidations
- Break below $869 (stop, 4.5%) = momentum failure; exit
- GDP Q1 revision (Thu) shows contraction or sharp deceleration = cyclical headwind
- China construction data weakness (CAT has significant China mining/construction exposure)
- Hot PCE triggers broad cyclical sell-off; industrials de-rate with the market
Entry: $901–$920
Stop Loss: $869.00
TP1: $972.00
TP2: $1,015.00
R/R: 1:1.51
Horizon: 10 days
ETF 📊
Momentum
Score 87
Defensive + GLP-1
CONV
XLV is the healthcare sector ETF providing portfolio-level defensive exposure with GLP-1 upside optionality. The ETF holds LLY (9.3%), UNH (7.8%), ABBV (6.2%), JNJ (5.8%), MRK (4.9%) — a diversified mix of growth pharma and defensive healthcare names. BUY signal Apr 30 with RSI at 57.5 and MACD bullish crossover (0.55 > 0.00) confirms early momentum. The lowest-volatility name in the scan (ATR 2.07) with the tightest risk profile (3.0% stop). Healthcare is the natural hedge for PCE risk: if hot print compresses tech multiples, healthcare rotates in as defensive quality. XLV has underperformed XLK by 15pp YTD — a catch-up trade into summer.
✅ Confirmations
- BUY signal Apr 30; RSI 57.5 with MACD bullish crossover — early momentum phase
- Diversified: LLY 9.3% (GLP-1), UNH 7.8% (managed care), ABBV 6.2% (immunology)
- Lowest ATR in scan (2.07) = tightest risk profile; ideal for reduced-size regime-penalty positioning
- Healthcare = natural PCE hedge: defensive if hot print, GLP-1 upside if market holds
- 15pp YTD underperformance vs XLK = sector catch-up trade potential through summer
❌ Invalidations
- Break below $144.50 (stop, 3.0%) = below EMA50/EMA200 cluster; exit
- UNH regulatory headline risk (DOJ investigation, PBM reform) weighs on ETF despite diversification
- Drug pricing legislation expansion under IRA = sector-wide margin compression risk
- Broad risk-off with VIX above 25 drags even defensive sectors; healthcare not immune
Entry: $147–$150
Stop Loss: $144.50
TP1: $156.00
TP2: $160.00
R/R: 1:1.56
Horizon: 15 days